{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T07:11:30Z","timestamp":1763968290550,"version":"3.41.2"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR1738, CO912\/2-1, 1192"],"award-info":[{"award-number":["FOR1738, CO912\/2-1, 1192"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["03Z22JN12, 01EO1502"],"award-info":[{"award-number":["03Z22JN12, 01EO1502"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["2012-305608"],"award-info":[{"award-number":["2012-305608"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01459","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T04:34:05Z","timestamp":1529901245000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Modeling Hemolytic-Uremic Syndrome: In-Depth Characterization of Distinct Murine Models Reflecting Different Features of Human Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Sophie","family":"Dennhardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiebke","family":"Pirschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianka","family":"Wissuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Gunzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Lindig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Medyukhina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kiehntopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram W.","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter F.","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Gunzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc Thilo","family":"Figge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina M.","family":"Coldewey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0140-6736(83)91795-6","article-title":"Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools","volume":"1","author":"Karmali","year":"1983","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1385\/MB:26:2:117","article-title":"Infection by Shiga toxin-producing Escherichia coli: an overview","volume":"26","author":"Karmali","year":"2004","journal-title":"Mol Biotechnol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/infdis\/jix305","article-title":"Streptococcus pneumoniae from patients with hemolytic uremic syndrome binds human plasminogen via the surface protein PspC and uses plasmin to damage human endothelial cells","volume":"217","author":"Meinel","year":"2018","journal-title":"J Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0034-1375296","article-title":"Genetics of atypical hemolytic uremic syndrome (aHUS)","volume":"40","author":"Rodriguez De Cordoba","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"B6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1086\/341940","article-title":"Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997\u20132000, in Germany and Austria: a prospective study","volume":"186","author":"Gerber","year":"2002","journal-title":"J Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","article-title":"Non-enteropathic hemolytic uremic syndrome: causes and short-term course","volume":"43","author":"Constantinescu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1106483","article-title":"Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany","volume":"365","author":"Frank","year":"2011","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/toxins4111261","article-title":"Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals","volume":"4","author":"Mayer","year":"2012","journal-title":"Toxins (Basel)"},{"key":"B11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/JCM.37.3.497-503.1999","article-title":"Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans","volume":"37","author":"Boerlin","year":"1999","journal-title":"J Clin Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1099\/jmm.0.05160-0","article-title":"Subtyping of virulence genes in verocytotoxin-producing Escherichia coli (VTEC) other than serogroup O157 associated with disease in the United Kingdom","volume":"52","author":"Jenkins","year":"2003","journal-title":"J Med Microbiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1128\/JCM.02591-06","article-title":"Subtyping method for Escherichia coli Shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations","volume":"45","author":"Persson","year":"2007","journal-title":"J Clin Microbiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12879-015-1017-6","article-title":"Shiga toxin-producing Escherichia coli infections in Norway, 1992\u20132012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome","volume":"15","author":"Brandal","year":"2015","journal-title":"BMC Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00418-001-0346-2","article-title":"Pathways followed by ricin and Shiga toxin into cells","volume":"117","author":"Sandvig","year":"2002","journal-title":"Histochem Cell Biol"},{"key":"B16","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1016\/S0021-9258(18)45660-8","article-title":"The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins","volume":"262","author":"Endo","year":"1987","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1203\/00006450-200108000-00002","article-title":"Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome","volume":"50","author":"Proulx","year":"2001","journal-title":"Pediatr Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1160\/TH05-04-0265","article-title":"Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium","volume":"94","author":"Bielaszewska","year":"2005","journal-title":"Thromb Haemost"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0002-9440(10)65380-1","article-title":"Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1","volume":"154","author":"Taylor","year":"1999","journal-title":"Am J Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ajpath.2012.12.026","article-title":"Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli Shiga toxins in non-human primate models of hemolytic uremic syndrome","volume":"182","author":"Stearns-Kurosawa","year":"2013","journal-title":"Am J Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/030098589303000502","article-title":"Clinical signs and lesions in gnotobiotic pigs inoculated with Shiga-like toxin I from Escherichia coli","volume":"30","author":"Dykstra","year":"1993","journal-title":"Vet Pathol"},{"key":"B22","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1128\/IAI.63.9.3621-3627.1995","article-title":"The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection","volume":"63","author":"Tzipori","year":"1995","journal-title":"Infect Immun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-4899-1828-4_6","article-title":"Variation in virulence in the gnotobiotic pig model of O157:H7 Escherichia coli strains of bovine and human origin","volume":"412","author":"Baker","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1309\/UMW9-D06Q-M94Q-JGH2","article-title":"Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli","volume":"118","author":"Gunzer","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13099-017-0179-8","article-title":"Comparison of clinical and immunological findings in gnotobiotic piglets infected with Escherichia coli O104:H4 outbreak strain and EHEC O157:H7","volume":"9","author":"W\u00f6chtl","year":"2017","journal-title":"Gut Pathog"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1086\/501364","article-title":"Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli","volume":"193","author":"Garcia","year":"2006","journal-title":"J Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.micinf.2008.03.004","article-title":"Intravenous Shiga toxin 2 promotes enteritis and renal injury characterized by polymorphonuclear leukocyte infiltration and thrombosis in Dutch Belted rabbits","volume":"10","author":"Garcia","year":"2008","journal-title":"Microbes Infect"},{"key":"B28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1574-695X.1997.tb01027.x","article-title":"Shiga toxin induces medullary tubular injury in isolated perfused rat kidneys","volume":"18","author":"Shibolet","year":"1997","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.1128\/IAI.73.11.7099-7106.2005","article-title":"Shiga toxin 1 causes direct renal injury in rats","volume":"73","author":"Yamamoto","year":"2005","journal-title":"Infect Immun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000319444","article-title":"Characterization of stx2 tubular response in a rat experimental model of hemolytic uremic syndrome","volume":"32","author":"Ochoa","year":"2010","journal-title":"Am J Nephrol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00467-003-1395-7","article-title":"Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin","volume":"19","author":"Ikeda","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1681\/ASN.2006050419","article-title":"A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease","volume":"17","author":"Keepers","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1128\/IAI.00592-08","article-title":"Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody","volume":"76","author":"Sauter","year":"2008","journal-title":"Infect Immun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"258185","DOI":"10.1155\/2011\/258185","article-title":"Mouse models of Escherichia coli O157:H7 infection and Shiga toxin injection","volume":"2011","author":"Mohawk","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-109-9-705","article-title":"Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum","volume":"109","author":"Griffin","year":"1988","journal-title":"Ann Intern Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1182\/blood-2002-10-3301","article-title":"Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells","volume":"102","author":"Matussek","year":"2003","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"F785","DOI":"10.1152\/ajprenal.00488.2015","article-title":"Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL\/6 mice","volume":"310","author":"Mulay","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang Da","year":"2009","journal-title":"Nat Protoc"},{"key":"B39","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/toxins7010170","article-title":"Shiga toxin 2-induced endoplasmic reticulum stress is minimized by activated protein C but does not correlate with lethal kidney injury","volume":"7","author":"Parello","year":"2015","journal-title":"Toxins (Basel)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.2174\/1381612822666160628080350","article-title":"Development of a mouse model of Shiga Toxin 2 (Stx2) intoxication for testing therapeutic agents against hemolytic uremic syndrome (HUS)","volume":"22","author":"Mejias","year":"2016","journal-title":"Curr Pharm Des"},{"key":"B41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1365-2249.2000.01103.x","article-title":"Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality","volume":"119","author":"Palermo","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2310\/7290.2008.00022","article-title":"In vivo tumor targeting by the B-subunit of Shiga toxin","volume":"7","author":"Viel","year":"2008","journal-title":"Mol Imaging"},{"key":"B43","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/fpd.2013.1704","article-title":"Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis","volume":"11","author":"Majowicz","year":"2014","journal-title":"Foodborne Pathog Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1128\/IAI.01663-06","article-title":"Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome","volume":"75","author":"Keepers","year":"2007","journal-title":"Infect Immun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2353\/ajpath.2007.060366","article-title":"CXCL1\/KC and CXCL2\/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation","volume":"170","author":"Roche","year":"2007","journal-title":"Am J Pathol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0022-3476(05)82049-9","article-title":"High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome","volume":"119","author":"Bitzan","year":"1991","journal-title":"J Pediatr"},{"key":"B48","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/CDLI.6.5.773-773.1999","article-title":"Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome","volume":"6","author":"Proulx","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1056\/NEJM197804272981702","article-title":"Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes","volume":"298","author":"Koster","year":"1978","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1128\/IAI.01435-09","article-title":"Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli","volume":"78","author":"Stearns-Kurosawa","year":"2010","journal-title":"Infect Immun"},{"key":"B51","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1172\/JCI57313","article-title":"The CXCR4\/CXCR7\/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice","volume":"122","author":"Petruzziello-Pellegrini","year":"2012","journal-title":"J Clin Invest"},{"key":"B52","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3265\/Nefrologia.pre2012.Nov.11648","article-title":"Dehydration upon admission is a risk factor for incomplete recovery of renal function in children with haemolytic uremic syndrome","volume":"33","author":"Ojeda","year":"2013","journal-title":"Nefrologia"},{"key":"B53","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00467-014-2918-0","article-title":"Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome","volume":"30","author":"Ardissino","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1542\/peds.2005-0785","article-title":"Predictors of fatality in postdiarrheal hemolytic uremic syndrome","volume":"117","author":"Oakes","year":"2006","journal-title":"Pediatrics"},{"key":"B55","doi-asserted-by":"publisher","first-page":"51ra71","DOI":"10.1126\/scitranslmed.3001118","article-title":"A central role for free heme in the pathogenesis of severe sepsis","volume":"2","author":"Larsen","year":"2010","journal-title":"Sci Transl Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2249.2006.03155.x","article-title":"Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia","volume":"146","author":"Fernandez","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","article-title":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000450609","article-title":"Decreased neutrophil extracellular trap degradation in Shiga toxin-associated haemolytic uraemic syndrome","volume":"9","author":"Leffler","year":"2017","journal-title":"J Innate Immun"},{"key":"B59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2015.02.002","article-title":"Mitochondria in the regulation of innate and adaptive immunity","volume":"42","author":"Weinberg","year":"2015","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/infdis\/jiv540","article-title":"Shiga toxin 2a-induced endothelial injury in hemolytic uremic syndrome: a metabolomic analysis","volume":"213","author":"Betzen","year":"2016","journal-title":"J Infect Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1160\/TH13-05-0387","article-title":"Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS)","volume":"111","author":"Lukasz","year":"2014","journal-title":"Thromb Haemost"},{"key":"B62","doi-asserted-by":"crossref","first-page":"15484","DOI":"10.1016\/S0021-9258(18)82282-7","article-title":"Endothelial heterogeneity in Shiga toxin receptors and responses","volume":"268","author":"Obrig","year":"1993","journal-title":"J Biol Chem"},{"key":"B63","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fimmu.2015.00155","article-title":"Pro-coagulant endothelial dysfunction results from EHEC Shiga toxins and host damage-associated molecular patterns","volume":"6","author":"Mayer","year":"2015","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/path.4388","article-title":"Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure","volume":"234","author":"Porubsky","year":"2014","journal-title":"J Pathol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/BF00858440","article-title":"A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the Southwest Pediatric Nephrology Study Group","volume":"4","author":"Argyle","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s004670050337","article-title":"Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome. British Association for Paediatric Nephrology","volume":"11","author":"Inward","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1046\/j.1523-1755.2002.00502.x","article-title":"Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model","volume":"62","author":"Rutjes","year":"2002","journal-title":"Kidney Int"},{"key":"B68","doi-asserted-by":"publisher","first-page":"9281","DOI":"10.1021\/jf101744z","article-title":"Ingested Shiga toxin 2 (Stx2) causes histopathological changes in kidney, spleen, and thymus tissues and mortality in mice","volume":"58","author":"Rasooly","year":"2010","journal-title":"J Agric Food Chem"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1128\/IAI.01264-13","article-title":"Oral intoxication of mice with Shiga toxin type 2a (Stx2a) and protection by anti-Stx2a monoclonal antibody 11E10","volume":"82","author":"Russo","year":"2014","journal-title":"Infect Immun"},{"key":"B70","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1128\/IAI.00679-08","article-title":"Shiga toxin 2 targets the murine renal collecting duct epithelium","volume":"77","author":"Psotka","year":"2009","journal-title":"Infect Immun"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1086\/344515","article-title":"Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome","volume":"71","author":"Sanchez-Corral","year":"2002","journal-title":"Am J Hum Genet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1681\/ASN.2013050450","article-title":"Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement","volume":"25","author":"Locatelli","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.4049\/jimmunol.1502377","article-title":"Early terminal complement blockade and C6 deficiency are protective in enterohemorrhagic Escherichia coli-infected mice","volume":"197","author":"Arvidsson","year":"2016","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01459\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T07:29:52Z","timestamp":1661498992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01459\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":75,"alternative-id":["10.3389\/fimmu.2018.01459"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01459","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2018,6,25]]},"article-number":"1459"}}